Infliximab and Basiliximab for Treatment of Steroid Refractory Acute Graft Versus Host Disease
Clinical trial NCT01485055 · TERMINATED
Trial details
- NCT number
- NCT01485055
- Sponsor
- Nationwide Children's Hospital
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-12-01
- Primary completion
- 2015-12-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.